SCHEMBL27628922

SCHEMBL27628922

Cc1c(Br)c2ccccc2oc1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.62
HSD17B10 Q99714 5/20 0.50
MAOA P21397 2/20 0.49
ALDH1A1 P00352 7/20 0.48
GAA P10253 4/20 0.48
MAPT P10636 3/20 0.47
CYP3A4 P08684 3/20 0.47
HPGD P15428 3/20 0.47
GLA P06280 1/20 0.47
PGAM1 P18669 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
ALDH2 P05091 1/20 0.44
MAPK1 P28482 2/20 0.43
ABCB11 O95342 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22780916 0.85 KDM4E (0.58) KDM4EHSD17B10MAOAALDH1A1GAA
SCHEMBL2450078 0.84 KDM4E (0.71) KDM4EHSD17B10MAOAALDH1A1GAA
SCHEMBL5472418 0.82 HSD17B10 (0.54) KDM4EHSD17B10MAOAALDH1A1GAA
SCHEMBL30050788 0.77 KDM4E (0.58) KDM4EHSD17B10MAOAALDH1A1GAA
SCHEMBL1992305 0.77 KDM4E (0.62) KDM4EHSD17B10MAOAALDH1A1GAA
SCHEMBL5459905 0.77 KDM4E (1.00) KDM4EALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL669541 0.77 KDM4E (0.58) KDM4EHSD17B10MAOAALDH1A1GAA
SCHEMBL94134 0.77 GAA (0.69) KDM4EHSD17B10ALDH1A1GAAMAPT
SCHEMBL29695571 0.77 KDM4E (1.00) KDM4EALDH1A1MAPTCYP3A4SMN1; SMN2
SCHEMBL31178946 0.77 GAA (0.69) KDM4EHSD17B10ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107674077-A 8 [base of 3 amino piperidine 1] Xanthine compounds, its preparation method and purposes as pharmaceutical preparation 勃林格殷格翰制药两合公司 2018-02-09 CN disclosed
CN-105001222-B 8 [base of 3 amino piperidine 1] Xanthine compounds, its preparation method and purposes as pharmaceutical preparation 勃林格殷格翰制药两合公司 2017-11-07 CN disclosed
CN-102964347-B 8-[3-amino-piperadine-1-base]-Xanthine compounds, its preparation method and the purposes as pharmaceutical preparation BOEHRINGER INGELHEIM PHARMACEUTICAL CO., LTD. (DE) 2015-11-18 CN disclosed
CN-105001222-A New 8-(3-amino-piperidin-1-yl)-xanthine derivatives, preparing method and uses thereof as a pharmaceutic preparation BOEHRINGER INGELHEIM PHARMA 2015-10-28 CN disclosed
CN-101503409-B 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments BOEHRINGER INGELHEIM PHARMA 2014-01-22 CN disclosed
CN-101503408-B 8-(3-amino-piperidin-1-yl)-xanthines BEOEHRINGER INGELHEIM PHARMA GMBH & CO KG 2013-04-24 CN disclosed
CN-102964347-A 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments BOEHRINGER INGELHEIM PHARMA 2013-03-13 CN disclosed
CN-101503408-A 8-(3-amino-piperidin-1-yl)-xanthines BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 CN disclosed
CN-101503409-A 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 CN disclosed
CN-100522962-C 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-05 CN disclosed
CN-1675212-A 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations BOEHRINGER INGELHEIM PHARMA (DE) 2005-09-28 CN disclosed